Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction
- PMID: 20652058
- PMCID: PMC2905945
- DOI: 10.1155/2010/878709
Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction
Abstract
Hypoxia is a condition of low oxygen tension occurring in the tumor and negatively correlated with the progression of the disease. We studied the gene expression profiles of nine neuroblastoma cell lines grown under hypoxic conditions to define gene signatures that characterize hypoxic neuroblastoma. The l(1)-l(2) regularization applied to the entire transcriptome identified a single signature of 11 probesets discriminating the hypoxic state. We demonstrate that new hypoxia signatures, with similar discriminatory power, can be generated by a prior knowledge-based filtering in which a much smaller number of probesets, characterizing hypoxia-related biochemical pathways, are analyzed. l(1)-l(2) regularization identified novel and robust hypoxia signatures within apoptosis, glycolysis, and oxidative phosphorylation Gene Ontology classes. We conclude that the filtering approach overcomes the noisy nature of the microarray data and allows generating robust signatures suitable for biomarker discovery and patients risk assessment in a fraction of computer time.
Figures


Similar articles
-
The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.BMC Genomics. 2009 Oct 15;10:474. doi: 10.1186/1471-2164-10-474. BMC Genomics. 2009. PMID: 19832978 Free PMC article.
-
A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.Mol Cancer. 2010 Jul 12;9:185. doi: 10.1186/1476-4598-9-185. Mol Cancer. 2010. PMID: 20624283 Free PMC article.
-
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.Oncotarget. 2016 Nov 22;7(47):76816-76826. doi: 10.18632/oncotarget.12713. Oncotarget. 2016. PMID: 27765905 Free PMC article.
-
Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.Pediatr Blood Cancer. 2015 Apr;62(4):581-6. doi: 10.1002/pbc.25348. Epub 2015 Jan 28. Pediatr Blood Cancer. 2015. PMID: 25630799 Free PMC article.
-
Time-dependent changes in ARE-driven gene expression by use of a noise-filtering process for microarray data.Physiol Genomics. 2002;9(3):137-44. doi: 10.1152/physiolgenomics.00003.2002. Epub 2002 Apr 9. Physiol Genomics. 2002. PMID: 12045294
Cited by
-
A computational procedure for functional characterization of potential marker genes from molecular data: Alzheimer's as a case study.BMC Med Genomics. 2011 Jul 5;4:55. doi: 10.1186/1755-8794-4-55. BMC Med Genomics. 2011. PMID: 21726470 Free PMC article.
-
Artificial neural network classifier predicts neuroblastoma patients' outcome.BMC Bioinformatics. 2016 Nov 8;17(Suppl 12):347. doi: 10.1186/s12859-016-1194-3. BMC Bioinformatics. 2016. PMID: 28185577 Free PMC article.
-
Transplantation Induces Profound Changes in the Transcriptional Asset of Hematopoietic Stem Cells: Identification of Specific Signatures Using Machine Learning Techniques.J Clin Med. 2020 Jun 1;9(6):1670. doi: 10.3390/jcm9061670. J Clin Med. 2020. PMID: 32492887 Free PMC article.
-
Hexokinase 2 is a determinant of neuroblastoma metastasis.Br J Cancer. 2016 Mar 29;114(7):759-66. doi: 10.1038/bjc.2016.26. Epub 2016 Mar 17. Br J Cancer. 2016. PMID: 26986252 Free PMC article.
-
Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma.Mol Oncol. 2016 Nov;10(9):1461-1472. doi: 10.1016/j.molonc.2016.07.012. Epub 2016 Aug 18. Mol Oncol. 2016. PMID: 27599694 Free PMC article.
References
-
- Maris J, Hogarty M, Bagatell R, Cohn S. Neuroblastoma. The Lancet. 2007;369(9579):2106–2120. - PubMed
-
- Thiele CJ. Neuroblastoma. In: Master JRW, Palsson B, editors. Human Cell Culture. London, UK: Kluwer Academic; 1999. pp. 21–22.
-
- Weinstein JL, Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. Oncologist. 2003;8(3):278–292. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical